Can retroperitoneal lymphadenectomy be omitted in some patients after chemotherapy?

Urologic Clinics of North America

Volumn 25, Issue 3, 1998, Pages 479-484

  Foster, R S ^a   Donohue, J P ^a  

^a Department of Urology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; HUMAN; LYMPH NODE DISSECTION; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; NECROSIS; NON SEMINOMATOUS GERMINOMA; PRIORITY JOURNAL; REVIEW; SEMINOMA; SURGICAL APPROACH; TESTIS CANCER; TREATMENT INDICATION; TUMOR VOLUME;

EID: 0031928195     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70037-9     Document Type: Article

References (18)